Table 4. KRAS exon 2 mutations in CD166 positive and CD166 negative CAD.
CAD | c.35G>A (G12D) | c.35G>T (G12V) | c.38G>A (G13D) | c.34G>A (G12S) | Total |
---|---|---|---|---|---|
CD166 positive | 6/49 (12%) | 5/49 (10%) | 0/49 (0%) | 0/35 (0%) | 11 |
CD166 negative | 1/23 (4%) | 0/23 (0%) | 2/23 (9%) | 1/23 (4%) | 4 |
Total | 7 | 5 | 2 | 1 | 15 |